Lewis H. Titterton jr - Jul 27, 2023 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Director
Signature
/s/ Lewis H. Titterton, Jr.
Stock symbol
ANIX
Transactions as of
Jul 27, 2023
Transactions value $
$1
Form type
4
Date filed
7/31/2023, 06:36 PM
Previous filing
Jun 26, 2023
Next filing
Oct 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIX Common Stock Options Exercise $309K +120K +15.5% $2.58 894K Jul 27, 2023 Direct
transaction ANIX Common Stock Tax liability -$309K -87K -9.74% $3.55 807K Jul 27, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Options Exercise $0 -120K -100% $0.00* 0 Jul 27, 2023 Common Stock 120K $2.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting persons exercised the stock options at this time due to their expiration on November 8, 2023. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to cover the exercise price of the stock options.
F2 Right-To-Buy, pursuant to a stock option grant dated November 8, 2013.